58 related articles for article (PubMed ID: 16608897)
1. Chemoembolization for liver metastases from medullary thyroid carcinoma.
Fromigué J; De Baere T; Baudin E; Dromain C; Leboulleux S; Schlumberger M
J Clin Endocrinol Metab; 2006 Jul; 91(7):2496-9. PubMed ID: 16608897
[TBL] [Abstract][Full Text] [Related]
2. Medullary thyroid carcinoma (MTC): unusual metastatic sites.
Kazakou P; Simeakis G; Alevizaki M; Saltiki K
Endocrinol Diabetes Metab Case Rep; 2021 Sep; 2021():. PubMed ID: 34551391
[TBL] [Abstract][Full Text] [Related]
3. The role of hepatic trans-arterial chemoembolization in metastatic medullary thyroid carcinoma: a specialist center experience and review of the literature.
Grozinsky-Glasberg S; Bloom AI; Lev-Cohain N; Klimov A; Besiso H; Gross DJ
Eur J Endocrinol; 2017 Apr; 176(4):463-470. PubMed ID: 28100632
[TBL] [Abstract][Full Text] [Related]
4. Recent Updates on the Management of Medullary Thyroid Carcinoma.
Kim BH; Kim IJ
Endocrinol Metab (Seoul); 2016 Sep; 31(3):392-399. PubMed ID: 27586449
[TBL] [Abstract][Full Text] [Related]
5. Cabozantinib in progressive medullary thyroid cancer.
Elisei R; Schlumberger MJ; Müller SP; Schöffski P; Brose MS; Shah MH; Licitra L; Jarzab B; Medvedev V; Kreissl MC; Niederle B; Cohen EE; Wirth LJ; Ali H; Hessel C; Yaron Y; Ball D; Nelkin B; Sherman SI
J Clin Oncol; 2013 Oct; 31(29):3639-46. PubMed ID: 24002501
[TBL] [Abstract][Full Text] [Related]
6. Establishment and validation of a nomogram model for predicting distant metastasis in medullary thyroid carcinoma: An analysis of the SEER database based on the AJCC 8th TNM staging system.
Chen Z; Mao Y; You T; Chen G
Front Endocrinol (Lausanne); 2023; 14():1119656. PubMed ID: 36875492
[TBL] [Abstract][Full Text] [Related]
7. Medullary Thyroid Cancer: An Experience from a Tertiary Care Hospital of a Developing Country.
Khan SA; Aziz A; Esbhani UA; Masood MQ
Indian J Endocrinol Metab; 2022; 26(1):68-72. PubMed ID: 35662760
[TBL] [Abstract][Full Text] [Related]
8. Metastatic medullary thyroid carcinoma: a new way forward.
Angelousi A; Hayes AR; Chatzellis E; Kaltsas GA; Grossman AB
Endocr Relat Cancer; 2022 May; 29(7):R85-R103. PubMed ID: 35521769
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Outcomes and Causes of Death among Medullary Thyroid Carcinoma Patients with Distant Metastases.
Park H; Yang H; Heo J; Kim TH; Kim SW; Chung JH
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572897
[TBL] [Abstract][Full Text] [Related]
10. Medullary Thyroid Cancer - Feature Review and Update on Systemic Treatment.
Dabelić N; Jukić T; Fröbe A
Acta Clin Croat; 2020 Jun; 59(Suppl 1):50-59. PubMed ID: 34219884
[TBL] [Abstract][Full Text] [Related]
11. Interventional Radiology Approaches for Liver Metastases from Thyroid Cancer: A Case Series and Overview of the Literature.
Nervo A; Ragni A; Retta F; Calandri M; Gazzera C; Gallo M; Piovesan A; Arvat E
J Gastrointest Cancer; 2021 Sep; 52(3):823-832. PubMed ID: 33999355
[TBL] [Abstract][Full Text] [Related]
12. Differentiated Thyroid Cancer, From Active Surveillance to Advanced Therapy: Toward a Personalized Medicine.
Matrone A; Campopiano MC; Nervo A; Sapuppo G; Tavarelli M; De Leo S
Front Endocrinol (Lausanne); 2019; 10():884. PubMed ID: 31998228
[TBL] [Abstract][Full Text] [Related]
13. A primer on the genetics of medullary thyroid cancer.
Larouche V; Akirov A; Thomas CM; Krzyzanowska MK; Ezzat S
Curr Oncol; 2019 Dec; 26(6):389-394. PubMed ID: 31896937
[TBL] [Abstract][Full Text] [Related]
14. Sporadic Medullary Thyroid Carcinoma with Paraneoplastic Cushing Syndrome.
Pivovarova AI; Patrick S; Reddy PJ
Case Rep Endocrinol; 2019; 2019():6414921. PubMed ID: 31885947
[TBL] [Abstract][Full Text] [Related]
15. The added diagnostic value of complementary gadoxetic acid-enhanced MRI to
Puhr-Westerheide D; Cyran CC; Sargsyan-Bergmann J; Todica A; Gildehaus FJ; Kunz WG; Stahl R; Spitzweg C; Ricke J; Kazmierczak PM
Cancer Imaging; 2019 Nov; 19(1):73. PubMed ID: 31727170
[TBL] [Abstract][Full Text] [Related]
16. Medullary Thyroid Carcinoma: An Update on Imaging.
Kushchayev SV; Kushchayeva YS; Tella SH; Glushko T; Pacak K; Teytelboym OM
J Thyroid Res; 2019; 2019():1893047. PubMed ID: 31360432
[TBL] [Abstract][Full Text] [Related]
17. CT- and ultrasound-characteristics of hepatic lesions in patients with multiple endocrine neoplasia syndrome. A retrospective image review of 25 cases.
Fard N; Schlemmer HP; Raue F; Jobke B
PLoS One; 2019; 14(2):e0212865. PubMed ID: 30817772
[TBL] [Abstract][Full Text] [Related]
18. Navigating Systemic Therapy in Advanced Thyroid Carcinoma: From Standard of Care to Personalized Therapy and Beyond.
Rao SN; Cabanillas ME
J Endocr Soc; 2018 Oct; 2(10):1109-1130. PubMed ID: 30250937
[TBL] [Abstract][Full Text] [Related]
19. Current role of interventional radiology in the management of visceral and bone metastases from thyroid cancer.
Cazzato RL; Garnon J; Koch G; Shaygi B; Tsoumakidou G; Caudrelier J; Boatta E; Buy X; Palussiere J; Gangi A
Gland Surg; 2018 Apr; 7(2):80-88. PubMed ID: 29770304
[TBL] [Abstract][Full Text] [Related]
20. Treatment of hepatic metastases from medullary thyroid cancer with transarterial embolisation.
Hughes P; Healy NA; Grant C; Ryan JM
Eur Radiol Exp; 2017; 1(1):9. PubMed ID: 29708149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
